Home» Medical News

Medical News

» NHLBI Funds Preclinical Tests on Devices for Infants and Children with Congenital Heart Defects
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, has awarded four contracts totaling $23.6 million to begin preclinical testing of devices to help children born with congenital heart defects or those who develop heart failure.
05 Feb 2010 | Read


» Antibodies Against Abnormal Glycoproteins Identified as Possible Biomarkers for Cancer Detection
Scientists have found that cancer patients produce antibodies that target abnormal glycoproteins (proteins with sugar molecules attached) made by their tumors.
05 Feb 2010 | Read


» NIH Scientists Identify Maternal and Fetal Genes That Increase Preterm Birth Risk
Researchers at the National Institutes of Health have identified DNA variants in mothers and fetuses that appear to increase the risk for preterm labor and delivery.
05 Feb 2010 | Read


» NIA Funds Roybal Centers for Translational Research in Aging
The National Institute on Aging (NIA), part of the National Institutes of Health, today announced that it has renewed funding for nine Edward R. Roybal Centers for Research on Applied Gerontology and designated four new centers.
05 Feb 2010 | Read


» Panel Calls for Reducing Colorectal Cancer Deaths by Striking Down Barriers to Screening
Colorectal cancer is the second leading cause of cancer-related deaths in the United States. Despite evidence and guidelines supporting the value of screening for this disease, rates of screening for colorectal cancer are consistently lower than those for other types of cancer, particularly breast and cervical.
05 Feb 2010 | Read


» EU drugs agency signs accord with Ukrainian Ministry of Health
The European Union and Ukraine will share information on drugs more systematically in future, thanks to a Memorandum of Understanding (MoU) signed in Kiev today between the EU drugs agency (EMCDDA) and the Ukrainian Ministry of Health.
05 Feb 2010 | Read


» Board elects Portuguese member Joao Goulao as new EMCDDA Chairman
The EU drugs agency’s Management Board convened for a two-day meeting in Lisbon today, kicking off with elections for Chairman and Vice-Chairman of the Board.
05 Feb 2010 | Read


» 10 helpful tips to safeguard Alzheimer`s patients
PROVIDE INFORMATION TO HELP WITH SEARCH AND RESCUE:
05 Feb 2010 | Read


» GlaxoSmithKline announces reduction in the investment into treatments for pain and depression
GlaxoSmithKline today said it had posted a strong performance in a challenging year with a return to sales growth for the first time since 2007.
05 Feb 2010 | Read


» Ipsen debuts Decapeptyl in France, Recordati gains EU clearance for silodosin
French specialty drugmaker Ipsen and Swiss biopharmaceutical group Debiopharm have announced the launch by Ipsen in France of Decapeptyl (triptorelin embonate1)
05 Feb 2010 | Read


» Canada’s Labopharm receives US FDA approval for Oleptrol, which is now set to enter $11 billion US antidepressant market
The US Food and Drug Administration has approved Canadian company Labopharm’s Oleptrol (trazodone hydrochloride) extended release tablets, a novel once-daily formulation of the antidepressant trazodone, for the treatment of major depressive disorder (MDD) in adults.
05 Feb 2010 | Read


» Austria’s Apeiron sells rights to early-stage lung disease drug to GlaxoSmithKline for as much as $332 million
Privately-held Austrian biotechnology firm Apeiron Biologics AG has entered into an agreement granting UK drugs giant GlaxoSmithKline, granting the latter exclusive rights to APN01 (recombinant human angiotensin converting enzyme 2, rhACE2),
05 Feb 2010 | Read


» The “new” Pfizer sees 4th qtr s2009 sales and profit rocket, but 2010 guidance disappoints
Pfizer, already the world’s biggest pharmaceutical company just got bigger with its $68 billion acquisition of fellow USA-based Wyeth which completed last fall,
05 Feb 2010 | Read


» Johnson & Johnson Celebrates 65 Years of Trading on the NYSE
Caring for the world, one person at a time inspires and unites the people of Johnson & Johnson.
05 Feb 2010 | Read


» CPEX Pharmaceuticals Announces Appointment of New Chief Scientific Officer
CPEX Pharmaceuticals, Inc. announced the appointment of Nils Bergenhem, Ph.D., as its new Chief Scientific Officer, effective February 1, 2010. Dr. Bergenhem will succeed Fred Feldman, Ph.D.,
05 Feb 2010 | Read


General Search

Last medical tags:


Torisel, temsirolimus, Inlyta, chronic myeloid leukemia, bosutinib, Inlyta, renal cell carcinoma, kidney cancer, myelin, Tysabri, natalizumab, brain infection, progressive multifocal leukoencephalopathy, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, thoracic aortic transection, endovascular graft, methotrexate, Voraxaze, cancer chemotherapy drug, glucarpidase, Adcetris, bleomycin, multifocal leukoencephalopathy, CardioGen-82, radiation, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, raltegravir, Isentress, antiretroviral medicines, Theravance, Relovair, asthma, fluticasone, bronchitis, neuromuscular disease, SMA, muscle atrophy, Resolor, prokinetic, prucalopride, ADHD, psychiatric behavioural disorder, Venvanse, lisdexamfetamine dimesylate, type 2 diabetes mellitus, Actoplus Met XR, pioglitazone, Mylan, Eprosartan Mesylate Tablets, Teveten, antimicrobials, cephapirin, cephalosporin, teriflunomide, Rebif, alanine aminotransferase levels, flu-like symptoms, multiple sclerosis, electrical pulses, implantable pulse generator, Precision Plus Spinal Cord Stimulator, genetic blood clotting disorder, hemophilia A, Advate, bleeding episodes, heart failure, heart transplantation, Pediatric Medical Device Safety, pulsatile cardiac assist device, selective serotonin reuptake inhibitor, SSRI, pulmonary hypertension,
» All tags  
Sitemap